Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension

By Suzuki Emilio Rintaro   Meirelles Franklin Luciana   da Silva Luciano José Basilio   Figueiredo Carlos R. L.   Agostini Netto Joao   Batista Wagner Duarte  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1799-1805

Informa Healthcare

Access to resources Recommend Favorite

Ocular hypotensive efficacy and safety of travoprost 0.004% in inadequately controlled primary open-angle glaucoma or ocular hypertension: short-term, multicenter, prospective study

By Blini Mirella   Rossi Gemma Caterina Maria   Trabucchi Giuseppe   Curatola Maria R.   David Alessandro   Radaelli Rosella   Merlo Giancarlo   Ratiglia Roberto  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 57-63

Informa Healthcare

Access to resources Recommend Favorite

Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin–timolol fixed combinations in primary open-angle glaucoma

By Aptel F.   Denis P.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1949-1958

Informa Healthcare

Access to resources Recommend Favorite

Treatment efficacy and safety of canaloplasty for open‐angle glaucoma after 5 years

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 8, 2015-11 ,pp. : 768-771

John Wiley & Sons Inc

Access to resources Recommend Favorite

Agonistic β2 receptor autoantibodies in ocular hypertension and open‐angle glaucoma

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite